Our top line results, combined with our continued focus on disciplined operating expense management, resulted in a gap net income of $237.1 million and non-gap net income of $94.3 million for the quarter, which, as I mentioned, excludes the Janssen-backed royalties and associated interest of $197.1 million related to 2022.

Jul 26, 2023 / CFO / receipt, needs a key / Ian Brown, CFO | earnings call 2023-07-26 | transcript e5c0da73-40cc-48ae-9445-46f3fabee25b | chars 7024-7348 | segment 7

I'm pleased with these results, which reflect the company's progress over the last several years in fueling top-line growth through Alchemy's developed products, coupled with a continued focus on disciplined expense management and operational efficiencies.

Feb 16, 2022 / CFO / receipt, needs a key / Ian Brown, CFO | earnings call 2022-02-16 | transcript 129e00a7-83ec-4f30-ab64-b9d6a60a8ef1 | chars 8464-8720 | segment 8

SG&A expenses for 2020 decreased to $538.8 million from $599.4 million in 2019, reflecting the impact in 2020 of the 2019 restructuring of COVID and ongoing expense management measures during the year.

Feb 11, 2021 / CFO / receipt, needs a key / Ian Brown, CFO | earnings call 2021-02-11 | transcript 52010326-8fb5-4317-971b-862b9d05cbf7 | chars 10861-11062 | segment 11